(Q35595419)

9 August 2017

1 reference

title

Liposome-based approaches to overcome anticancer drug resistance (English)

1 reference

9 August 2017

Christoph Mamot

1

0 references

Dmitri B. Kirpotin

object named as

Dmitri B Kirpotin

4

0 references

author name string

Daryl C Drummond

2

1 reference

9 August 2017

Keelung Hong

3

1 reference

9 August 2017

John W Park

5

1 reference

9 August 2017

publication date

1 October 2003

1 reference

9 August 2017

published in

Drug Resistance Updates

1 reference

9 August 2017

volume

6

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

271-279

1 reference

Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Expression of the human multidrug resistance and glucocerebrosidase cDNAs from adeno-associated vectors: efficient promoter activity of AAV sequences and in vivo delivery via liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Distribution of AAV-TK following intracranial convection-enhanced delivery into rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Current status of pH-sensitive liposomes in drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

By-passing of P-glycoprotein using immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol).

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

An episomally maintained MDR1 gene for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Phospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Folate-mediated delivery of macromolecular anticancer therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Liposomal formulations of anticancer drugs: selectivity and effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Antiproliferative activity of thermosensitive liposome-encapsulated doxorubicin combined with 43 degrees C hyperthermia in sensitive and multidrug-resistant MCF-7 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Liposome-encapsulated daunorubicin for PGP-related multidrug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma. A phase II International Oncology Study Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Liposome-based drug delivery in breast cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Development of anti-p185HER2 immunoliposomes for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Immunoliposomes for cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Cationic liposomes for gene delivery: from biophysics to biological applications

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Drug-containing lipid vesicles render drug-resistant cell sensitive to actinomycin D

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

The (patho)physiological functions of the MRP family

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

Activation of the PI3K/Akt pathway and chemotherapeutic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2803%2900082-7

7 January 2021

10.1016/S1368-7646(03)00082-7

Identifiers

DOI

1 reference

9 August 2017

1 reference